Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/ys-biopharma-announces-name-change-to-lakeshore-biopharma-302155079.html
https://www.prnewswire.com/news-releases/ys-biopharma-announces-results-of-extraordinary-general-meeting-302151701.html
https://www.prnewswire.com/news-releases/ys-biopharma-to-hold-extraordinary-general-meeting-on-may-21-2024-and-announces-the-appointment-of-interim-chief-executive-officer-302138588.html
https://www.prnewswire.com/news-releases/ys-biopharma-receives-additional-180-day-extension-by-nasdaq-to-regain-compliance-with-minimum-bid-price-rule-302129986.html
https://www.prnewswire.com/news-releases/ys-biopharma-announces-unaudited-financial-results-for-the-first-nine-months-of-fiscal-year-2024-302121952.html
https://www.prnewswire.com/news-releases/ys-biopharma-granted-phase-i-clinical-trial-license-of-therapeutic-chronic-hepatitis-b-virus-vaccine-302120805.html
https://www.fiercebiotech.com/biotech/ys-biopharmas-rabies-vaccine-bests-approved-competitor-interim-phase-3-readout
https://www.prnewswire.com/news-releases/ys-biopharma-announces-positive-interim-results-of-pivotal-phase-3-clinical-study-of-pika-rabies-vaccine-302111651.html
https://www.prnewswire.com/news-releases/ys-biopharma-announces-full-repayment-of-us40-000-000-loan-facility-302107132.html
https://www.prnewswire.com/news-releases/ys-biopharma-announces-board-changes-and-strategic-leadership-appointments-in-chinese-subsidiaries-302079837.html